These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5018858)

  • 1. [Normal plasma free fatty acid (C 16 -C 18 ) values in diabetics after treatment with an oral hypoglycemizing agent].
    Bertolini AM; Santagostino A
    Minerva Med; 1972 Mar; 63(20):1145-9. PubMed ID: 5018858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of therapy and adjustment of diabetics with xanthine nicotinate].
    Hahn J; Kaffarnik H
    Med Klin; 1969 May; 64(22):1042-5. PubMed ID: 5800195
    [No Abstract]   [Full Text] [Related]  

  • 3. Diurnal variations in blood glucose, 3-hydroxybutyrate, acetoacetate, plasma free fatty acids and glycerol in diabetics.
    Rooth G; Carlström S
    Acta Med Scand; 1972 Jun; 191(6):559-63. PubMed ID: 5038229
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development, after oral dose of carbutamide in diabetics, of plasma levels of glucose, insulin, free fatty acids and sulfonamide].
    Mantel O; Fiet J; Dreux C; Canivet J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():293-300. PubMed ID: 5376987
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Free fatty acids and glucose in the blood of insulin resistant diabetics].
    Fischer U; Lippmann HG
    Z Gesamte Inn Med; 1968 Aug; 23(15):Suppl:226-8. PubMed ID: 5678679
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of plasma free fatty acids associated with diabetes treated by glyconormal: 30 clinical cases].
    Warembourg H; Jaillard J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():431-4. PubMed ID: 5377003
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
    Ulrich E; Frank I; Kujat G; Müller G; Seige K
    Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
    [No Abstract]   [Full Text] [Related]  

  • 10. [Better blood sugar control in diabetics. Insulin glargin--a long-acting insulin analogue].
    Schubert-Zsilavecz M; Wurglics M
    Pharm Unserer Zeit; 2001; 30(2):125-30. PubMed ID: 11279982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
    Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvement of oral glucose tolerance through acute medicamentous reduction of free fatty acids in the plasma].
    Büber V; Felber JP; Vannotti A
    Schweiz Med Wochenschr; 1968 May; 98(19):711-3. PubMed ID: 5700753
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on fatty acid metabolism in diabetics during exercise. V. Plasma concentration of free fatty acids and glycerol in newly diagnosed, adult diabetics during exercise.
    Carlström S
    Acta Med Scand; 1967 Sep; 182(3):363-76. PubMed ID: 6058365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes].
    Kosaka K; Hagura R; Ogawara H
    Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200
    [No Abstract]   [Full Text] [Related]  

  • 16. [Attempts of modification of the serum lipid fractions in diabetics].
    Krámer M; Balogh P
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):345-51. PubMed ID: 5731589
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic and hormonal profile of the offsprings of conjugal diabetics.
    Mahtab H; Ara S; Banik NG; Chowdhury NA; Azad Khan AK
    Bangladesh Med Res Counc Bull; 1982 Jun; 8(1):7-14. PubMed ID: 6756373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of treatment with insulin or diet on intermediary metabolites in pregnant women with chemical diabetes in the third trimester of pregnancy.
    Stangenberg M; Persson B; Lunell NO; Hanson U
    Acta Diabetol Lat; 1984; 21(1):55-61. PubMed ID: 6375226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.